Active: new deal Sep 2026 Verified 7 Nov 2026
Hadean Ventures
European life science venture capital fund manager with about EUR 230 million under management that invests in therapeutics, medical devices, diagnostics and digital health companies across the Nordics and wider Europe.
- Type
- VC firm
- Location
- Norway
- Stages
- Seed, Series A, Series B
- Sectors
- Healthtech and life sciences, Biotech, Medtech
- Fund size / AUM
- over EUR 230 million assets under management (own site)
- Website
- hadeanventures.com
Contacts on file
For Hadean Ventures, the paid file holds: 3 named decision-makers with roles; firm contact email (domain checked).
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
AblivaActitheraAlex TherapeuticsARTHEx BiotechAttgeno
Sources
- hadeanventures.com/
- hadeanventures.com/portfolio/
- hadeanventures.com/team/
- registers.esma.europa.eu/publication/searchRegister?core=esma_registers_funds
- nvca.no/liste-medlem-medlemmer
- www.investeurope.eu/membership/member-search/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 25 lists
Venture capital firms in Norway (27)Startup investors in Norway (41)Medtech investors in Europe (45)Series B medtech investors (57)Series B biotech investors (73)Biotech investors in Europe (89)Series B investors in Europe (117)Series A medtech investors (125)Series A biotech investors (153)Series B healthtech investors (160)Seed medtech investors (278)Healthtech investors in Europe (291)Seed biotech investors (300)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Venture capital firms in Europe (412)Medtech investors (457)Biotech investors (484)Seed investors in Europe (543)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)